Breathing Rescue for SUDEP Prevention
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT05981755
- Status
- Recruiting
Conditions
- Focal Epilepsy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Breathing tasks — OTHERBreathing tasks include normal breathing through nose or mouth, breathing while resting wakefully, increase and decrease in breathing rate, and breath counting.
- Brain mapping with stimulation — DEVICEElectrical stimulation will be used to find specific areas of the brain involved in breathing function. Stimulation will be applied using a Nihon Kohden MEE-1000A neural function measuring system with the MS-120BK extension unit for brain stimulation.
Study Details
The purpose of this study is to precisely delineate human brain networks that modulate respiration and identify specific brain areas and stimulation techniques that can be used to prevent seizure-induced breathing failure.
Key Dates
- Start date
- Jul 31, 2023
- Status verified
- Jun 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Breathing tasks and Brain mapping with stimulation
Primary Outcome Measure
Change in percentage of breathing node size as assessed by electroencephalogram (EEG) signal [ Time Frame: baseline (before breathing task), at the time of the breathing task (about 8 minutes after start of baseline) ]
Central Contacts
- Nuria L Lecumberri, MD,PhD713-500-7785
- Sandhya Rani, PhD713-500-7499
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- An Open-label Study of XEN1101 in EpilepsyPHASE3 · Enrolling By Invitation · Xenon Pharmaceuticals Inc. · Phoenix, Arizona
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyPHASE2/PHASE3 · Recruiting · Biohaven Therapeutics Ltd. · Phoenix, Arizona
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyPHASE2/PHASE3 · Recruiting · Biohaven Therapeutics Ltd. · Birmingham, Alabama
- Long-term Safety and Tolerability of BHV-7000PHASE2 · Enrolling By Invitation · Biohaven Therapeutics Ltd. · Birmingham, Alabama